beta
AEMD
Aethlon Medical Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression.
Market Cap: 16.5 Million
Primary Exchange: NASDAQ
Website: www.aethlonmedical.com
Shares Outstanding: 15.4 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.950694648509152
Sector: Manufacturing
Industry: Analytical Laboratory Instrument Manufacturing
Ethical Flags
Longest drawdown: 2580 trading days
From: 2014-11-24 To: 2022-05-19
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2015-04-14 | 50.0 | 1.0 | 50.0 |